Enrique Dilone

Enrique Dilone is a declared insider of Amicus Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 15 filings, for trades running from 10 April 2014 to 19 June 2015.

Both buying and selling appear: 4 purchases worth €129k, against 6 sales worth €542k. On balance, insiders were net sellers of €413k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants and 3 option exercises. 2015 to date brings no purchases and 3 sales.

In size, the median ticket on the buying side is €32k.

The record was last updated on 23 June 2015 with an open-market sale (€164k) in Amicus Therapeutics, Inc. The most recent open-market purchase was published on 25 November 2014, 4,367 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.